Announced Mon, 19 Jan · 21:11 IST
Torrent Pharmaceuticals Limited has informed the Exchange regarding allotment of 30000 securities pursuant to Commercial Papers at its meeting held on January 19, 2026
Fund Raising View source PDF
TORNTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
Torrent Pharmaceuticals has allotted 30,000 securities in the form of Commercial Papers at a board meeting held on January 19, 2026. Commercial Papers are short-term, unsecured debt instruments typically used by companies to meet immediate funding needs. The company has not disclosed the face value, total amount raised, or interest rate in this filing.
Likely market impact
This is a routine short-term debt issuance to raise working capital, not a major capital event. Shareholders are unlikely to see any meaningful impact on stock price, though it indicates normal treasury operations.